Bayer AG Logo

Bayer AG

A life science firm providing pharmaceuticals, consumer health, and crop science solutions.

BAY | F

Overview

Corporate Details

ISIN(s):
DE0005752059 (+2 more)
LEI:
549300J4U55H3WP1XT59
Country:
Germany
Address:
Kaiser-Wilhelm-Allee 1, 51373 Leverkusen
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bayer AG is a global life science company with core competencies in healthcare and agriculture. Guided by its mission, "Health for all, Hunger for none," the company develops and commercializes products and services designed to address fundamental human needs and global challenges. Its operations are organized into three divisions: Pharmaceuticals, which focuses on prescription products; Consumer Health, offering over-the-counter medications and supplements; and Crop Science, providing seeds, crop protection, and digital farming solutions. Bayer's portfolio includes numerous world-famous brands and aims to foster innovation in health and nutrition to support a growing and aging global population.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-02 12:09
Declaration of Voting Results & Voting Rights Announcements
English 12.6 KB
2025-08-06 00:00
Interim Report
Half-yearly financial report 2025
English 472.4 KB
2025-08-04 13:55
Major Shareholding Notification
English 86.6 KB
2025-07-31 23:15
Earnings Release
Bayer Aktiengesellschaft: Bayer upgrades currency-adjusted sales and earnings g…
English 12.2 KB
2025-07-24 14:09
Major Shareholding Notification
English 83.7 KB
2025-07-22 11:51
Declaration of Voting Results & Voting Rights Announcements
English 86.3 KB
2025-07-04 07:38
Declaration of Voting Results & Voting Rights Announcements
English 86.4 KB
2025-06-26 15:30
Declaration of Voting Results & Voting Rights Announcements
English 23.5 KB
2025-06-25 12:35
Declaration of Voting Results & Voting Rights Announcements
English 23.5 KB
2025-06-23 13:01
Declaration of Voting Results & Voting Rights Announcements
English 80.3 KB
2025-06-12 12:54
Declaration of Voting Results & Voting Rights Announcements
English 23.5 KB
2025-05-22 09:04
Major Shareholding Notification
English 23.4 KB
2025-05-21 14:01
Major Shareholding Notification
English 18.5 KB
2025-05-19 09:00
Declaration of Voting Results & Voting Rights Announcements
English 23.4 KB
2025-05-17 07:59
Declaration of Voting Results & Voting Rights Announcements
English 18.5 KB

Automate Your Workflow. Get a real-time feed of all Bayer AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bayer AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bayer AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AnGes, Inc. Logo
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan 4563
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom ANCR
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea 065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania ATB
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea 397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea 003060
Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea 007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea 293780

Talk to a Data Expert

Have a question? We'll get back to you promptly.